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Abstract
Background: As research into alternative splicing reveals the fundamental importance of this phenomenon in the genome
expression of higher organisms, there is an increasing need for a standardized, consistent and unique identifier for
alternatively spliced isoforms. Such an identifier would be useful to eliminate ambiguities in references to gene isoforms,
and would allow for the reliable comparison of isoforms from different sources (e.g., known genes vs. computational
predictions). Commonly used identifiers for gene transcripts prove to be unsuitable for this purpose.
Methodology: We propose an algorithm to compute an isoform signature based on the arrangement of exons and introns
in a primary transcript. The isoform signature uniquely identifies a transcript structure, and can therefore be used as a key in
databases of alternatively spliced isoforms, or to compare alternative splicing predictions produced by different methods. In
this paper we present the algorithm to generate isoform signatures, we provide some examples of its application, and we
describe a web-based resource to generate isoform signatures and use them in database searches.
Conclusions: Isoform signatures are simple, so that they can be easily generated and included in publications and databases,
but flexible enoughto unambiguously represent all possible isoform structures,including information about codingsequence
position and variable transcription start and end sites. We believe that the adoption of isoform signatures can help establish a
consistent, unambiguous nomenclature for alternative splicing isoforms. The system described in this paper is freely available
at http://genome.ufl.edu/genesig/, and supplementary materials can be found at http://genome.ufl.edu/genesig-files/.
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Introduction
Alternative splicing is emerging as a major molecular mecha-
nism to extend the repertoire of functions produced by individual
genes, through the expression of multiple transcripts encoding
proteins with different biochemical and physical properties, and to
diversify the regulation of their expression through alternative 59
and 39UTRs. It is now known that the majority of genes in higher
organisms are alternatively spliced [1–3]. The increasingly
important role of alternative splicing in many biological processes
[4,5] and its involvement in various diseases, including cancer
[6,7], has raised enormous interest in further understanding this
fundamental process. At the same time, the rapid development of
high-throughput RNA sequencing methods now provides a way to
observe splicing events directly and on a very large scale,
increasing the amount of data available on this phenomenon by
many orders of magnitude [1]. This in turn has promoted the
development of software algorithms for the computational
investigation of alternative splicing, and of specialized databases
collecting alternatively spliced gene isoforms from several species
with related structural and functional information [2,8–11].
In order to obtain a comprehensive overview of the splicing
pattern of a given gene and of its implications, it is in general
necessary to consider results obtained by different approaches,
both computational and experimental in nature, since no
individual method or algorithm is powerful and accurate enough
to provide a complete picture of such a complex biological
phenomenon. Combining and comparing splicing information
from different sources requires the ability to uniquely identify a
splicing isoform on the basis of its structure. For example, we may
be interested in determining whether a computationally predicted
splicing isoform matches an already known one, or one predicted
with a different method: accomplishing this by explicitly
comparing the arrangements of exons and introns is tedious and
error-prone. Using an identifier associated with the exon/intron
structure, these tasks would instead reduce to simple identifier
comparisons. The ability to uniquely identify a splicing isoform is
also useful to eliminate ambiguities when referring to locations
within a gene transcript. For example, the PKM2 gene in human
encodes for two different isoforms, denoted M1 and M2,
characterized by two mutually exclusive exons 9, corresponding
to the normal and cancer-specific isoform, respectively [12,13]. In
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isoform being considered is also specified, in an unambiguous way.
There have been several efforts aimed at developing a
standardized nomenclature for splicing events, and formalisms to
describe them. Sammeth et al. developed a notation that assigns a
unique code to every possible pattern of splicing variation [14].
The code is based on the relative positions of the the splice sites,
and can be used to automatically annotate the entire set of
alternative splicing events in a set of annotated transcripts. Lee
et al. proposed the use of splicing graphs to represent all possible
splicing isoforms generated by the same gene in graphical form
[15]. Similarly, Nagasaki et al. describe a method to represent and
classify every possible alternative splicing configuration using bit
vectors [16]. Although these solutions are very useful to classify
and describe patterns of splicing events, they do not directly
address the problem of identifying the transcripts produced by
those events in a general and exact way: there may easily be
isoforms produced by the same pattern of splicing events that
generate very different transcripts. Similarly, different splicing
patterns in different genes can result in isoforms that have exactly
the same structure. Finally, these representations are not compact
and readable enough to be used as identifiers in publications or in
database searches.
We therefore believe there is a need for a standardized and
consistent method to uniquely identify an alternatively spliced
isoform using a short and unambiguous identifier, whose purpose
is to describe its structure, in terms of the exact succession of exons
and introns that characterizes it, in a simple and concise way. The
identifier, called ‘‘isoform signature’’ in the remainder of this
paper, should have the following properties:
1. It should only depend on the lengths and relative positions of
the gene exons, and not on their absolute positions on a
chromosome (since they may not be known, or may change
when the genome is re-assembled), nor on their DNA
sequence.
2. It should take into account the fact that the transcription start
site (TSS) and the transcription termination site (TTS) cannot
always be determined exactly, and should therefore allow
identifying isoforms that differ only for the position of the TSS
and TTS within a specified range.
3. It should provide a way to optionally include information about
the position of the coding sequence, when known.
4. It should not depend on the gene name or other identifier, or
on the organism. On the contrary, one of the purposes of the
isoform signature is to possibly identify different genes having
isoforms with the same structure, possibly belonging to
different organisms.
5. It should be short and easy to compute, so that identifiers for
newly discovered isoforms can be quickly generated and easily
included into publications. It should also have a predictable
maximum length, in order to appropriately define the size of
fields to contain it in databases.
Existing identifiers for transcripts (such as NCBI’s ‘‘NM_’’
accessions or ENSEMBL ‘‘ENST’’ identifiers) are unsuitable for
this purpose, for several reasons: they are usually dependent on a
specific database, they only apply to known, observed isoforms,
and not to computationally predicted ones, and they do not
provide a way of detecting when isoforms from different genes in
the same or different organisms, or from the same gene with
different prediction methods, have the same structure, i.e. the
same number and size of exons and introns. More fundamentally,
the relationship between genes and transcripts is not bi-univocal:
there may be cases in which two paralogous copies of a gene with
identical structure produce different transcripts (if their corre-
sponding DNA sequence is different), or cases in which two gene
copies, although differing in structure, can produce the same
transcript (for example, if the difference consists in one or more
introns with different length).
In this paper we propose a method for the generation of an
isoform signature that satisfies the above outlined requirements.
We describe the algorithm used to compute the signature,
providing several examples showing how isoform signatures are
calculated, and we present an example of the use of isoform
signatures in a large-scale comparison between different databases
of alternative splicing information. Finally, we describe a web-
based application that we developed that allows users to generate
isoform signatures or to search a database of known and predicted
gene isoforms using their signatures.
Results
We define two different types of isoform signature: a basic one,
that only specifies the exon/intron structure of the isoform, and an
extended one that also encodes the start and end position of the
coding sequence (CDS). Although the CDS position is not
technically part of the isoform structure, its biological importance
is so high that we provide a way to include it in the signature when
it is known. An isoform signature is a short string composed of the
following three elements: a 10-character cryptographic identifier, a
separator character, and a number. The cryptographic identifier is
generated by encoding the arrangement of exons and introns in
the isoform as a character string and applying the SHA-1
cryptographic hash function to it, according to the algorithm
described in the Methods section. The separator character is a
pipe character (‘‘|’’) for basic signatures, and a colon character
(‘‘:’’) for signatures that include the CDS. The number appearing
after the separator character is the number of exons in the isoform.
The following are examples of isoform signatures:
‘‘40a6839e0b|9’’, ‘‘c58ffac1ac:9’’. The first one is a basic
signature, the second one includes CDS information.
In the remainder of this paper we show how isoform signatures
can be used to identify alternative splicing isoforms without
ambiguities, and to detect identities and similarities among
different isoforms. While the fact that two isoforms receive the
same identifier guarantees that their intron/exon structures are
identical, we provide methods to detect isoforms that differ only
for the position of the transcription start and end sites, and to take
into account the coding sequence position when known.
It is important to note that the isoform signature is a function
only of the length of the alternating exons and introns, not of their
actual position in the genome, nor of their DNA sequence. This is
intentional, because the purpose of the signature is to unequiv-
ocally identify an isoform structure, and to directly compare isoform
structures independently of their origin. On the other hand, the
signature generation algorithm is extremely sensitive to noise: a
change in the position of even a single intron/exon boundary will
result in a totally different signature. Biologically, a shift in the start
or end position of a coding exon, caused for example by an
insertion or by inaccurate splicing, can have dramatic conse-
quences, possibly causing a translation frame shift. In this case, we
believe it is appropriate for the isoform signature to change, since
the isoforms in question will clearly be distinct. The start and end
positions of the transcript are an exception, as noted above: real or
predicted isoforms that differ only for their TSS and TTS positions
can produce biologically equivalent transcripts. In our approach
we handle this issue through the use of normalized signatures that link
Unique Isoform Identifiers
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within a specified range.
A limitation of our proposed method is that, since the SHA-1
algorithm is not invertible, there is no direct way to ‘‘decode’’ an
isoform signature and retrieve the corresponding signature string.
This can be obviated by creating a database, such as the one
described below, associating isoform signatures with the informa-
tion used to generate them, including the organism name, gene
and transcript identifiers.
The Genesig server
We have developed an online application that implements the
isoform signature algorithm described in this paper. The system
allows users to easily compute the isoform signature for one or
more gene isoforms, and to decode it by searching a local database
of precomputed signatures.
The application can operate in two distinct modes: Generate and
Lookup. In Generate mode, it allows the user to compute the
signature string, the isoform signature, and the four normalized
signatures given an isoform structure. The structure can be
specified in one of several different ways:
1) By manually entering the start and end coordinates of the
exons or providing them in an uploaded file;
2) By uploading an annotated sequence file, in which the
locations of the exons are indicated by a change in case or
by special marker characters;
3) By uploading a file in GTF or Aceview format;
4) By entering a signature string.
In all cases, the user has the choice of generating an extended
isoform, by providing coding sequence position information, or a
basic one (see Figure 1). The application decodes the isoform
structure (or structures) described by the user’s input, generates the
corresponding signatures, and displays them on the resulting page
(see Figure 2). It should be noted that the system can generate
signatures for multiple isoforms at once, when the input comes
from an uploaded file. Each signature is a link to the Lookup
section of the application, described below: the user can thus
quickly verify whether a generated signature corresponds to a
known isoform. The results can also be downloaded to a text file,
so that they can easily be inserted in databases or used for further
processing.
Figure 1. The input form for the Generate section of the website. The user may specify the isoform structure(s) in a variety of different ways,
including pasting a specially-formatted FASTA sequence or uploading it from a file.
doi:10.1371/journal.pone.0007631.g001
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signature, a signature string, or a set of gene names, and retrieves
matching isoforms from its database. The user may optionally
specify whether to perform an ‘‘approximate’’ search (one that
uses the normalized signatures in addition to the main one) and
whether to take into account the position of the coding sequence
or ignore it (see Figure 3). Finally, the user may restrict the search
to a subset of the sources of isoform data included in the
application’s database (all of them are used by default). The
current version of the system includes isoform signatures for all
transcripts contained in the following databases: NCBI’s Refseq,
AspicDB [2], Aceview [10] and ASTD [9]. When a lookup is
successful, the system displays all matching isoforms found in the
database providing details about the source database they appear
in, the gene they belong to, and the structure of isoform, including
a graphical display of the exon/intron arrangement (see Figure 4).
As in the previous case, all results can be downloaded as a
delimited text file. The Lookup function can also be invoked using
a specially formatted URL that includes the signature: when
included in a web page, this URL will produce a link leading to the
page displaying the information about the corresponding isoform.
Finally, a History feature allows the user to list all the isoform
signatures generated or retrieved in the course of the current
session (see Figure 5). The user can choose to display each
individual set of signatures or to download the signature data to a
local file.
The application is web-based and can be freely accessed at the
URL http://genome.ufl.edu/genesig/. Extensive documentation
about the signature generation method and detailed help pages to
facilitate using the application are provided.
Application
We performed a large-scale comparison of the computationally
predicted alternative splicing isoforms of human genes contained
in three different databases: ASPICdb [2], ASTD [9], and
ACEVIEW [10]. Since these predictions were generated using
different methodologies, we were interested in evaluating the level
of agreement among them, as well as between each one of them
and the NCBI Refseq database. Refseq provides a comprehensive,
non-redundant and well-annotated set of transcript sequences for
several organisms, including several splicing isoforms (Refseq
release 32, of November 2008, contains 38,827 transcripts from
Figure 2. The output of the Generate command. For each supplied isoform, the system displays the signature string, the main and alternative
isoform signatures, and details of the isoform structure including its graphical representation.
doi:10.1371/journal.pone.0007631.g002
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provide an estimate of the quality of predicted splicing isoforms.
The comparison was performed by generating the signature for
every predicted transcript, and calculating the percentage of
matching isoforms for corresponding genes in each pair of
databases. We considered both exact matches and approximate
matches (those based on the alternative signatures), with or
without taking CDS information into account. Results are shown
in Table 1. ASPICdb exhibited the best performance in terms of
matching transcript signatures: using the approximate method,
91% of Refseq transcripts were correctly matched, with 93% of
genes showing at least one matching signature. Excluding the CDS
annotation from the signature definition, we obtained a slight
increase in the percentages of matching signatures (92% and 94%,
respectively). The percentage of matching isoform signatures
between Refseq and the two other databases was much lower,
ranging from 36% (ACEVIEW) to only 10% (ASTD), in the same
conditions. Concerning the pairwise comparisons between AS-
PICdb, ACEVIEW and ASTD, the number of matching
transcript signatures resulted generally low, ranging from 25%
(ACEVIEW vs ASTD) to 14% (ASPICdb vs ASTD), when using
the approximate method and without considering the CDS
(Table 2).
The results obtained suggest a generally low degree of
overlapping between alternatively spliced transcripts collected in
different databases as well as between these and RefSeq
transcripts, with the notable exception of ASPICdb. Assuming
that RefSeq transcripts represent the ‘‘gold standard’’, the
reliability of alternative isoforms predicted by ASPICdb is clearly
higher than that of those found in ACEVIEW and ASTD. The
better performance of ASPICdb can be partially explained by the
fact that, while ACEVIEW and ASTD only use available EST/
transcript data, ASPICdb uses EST/transcript data to generate
the full set of introns found in a given gene region, and applies a
combinatorial assembly algorithm to obtain all compatible full-
length isoforms [17]. Furthermore, different exon-intron structures
may be due to the use of different alignment algorithms [18]. For
example, in the case of the SLC22A7 gene transcript NM_153320,
a 6 bp microexon is detected by ASPICdb (but also appears in the
highly curated annotations provided by VEGA [19], see entry
OTTHUMT00000040588) but not by RefSeq, ACEVIEW or
ASTD. Therefore, ASPICdb shows a transcript with 11 exons,
Figure 3. The input form for the Lookup section of the website. The user may enter an isoform signature, a signature string, or a list of gene
names as the query term. It is also possible to specify what kind of search to perform (exact or approximate, with or without coding sequence
information) and the list of isoform databases to search.
doi:10.1371/journal.pone.0007631.g003
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can be very easily detected using our system, since they will result
in different isoform signatures. Finally, ASPICdb predictions are
based on data that are more up-to-date than those in ACEVIEW
and ASTD.
The Supplementary Materials site provides downloadable files
containing signatures for all gene isoforms in the four databases
considered in this study.
Discussion
As demonstrated by the cross-database comparison we
performed, different computational methods for the prediction of
splicing isoforms vary greatly in the number of predictions they
produce, in the concordance of their predictions with known,
manually validated isoforms, and in the level of agreement with
other similar resources. As our knowledge of the causes and
potential biological and clinical consequences of alternative
splicing grows, it will become increasingly important to have a
way of uniquely identifying splicing isoforms, so that information
like exon numbering and relative positions of genetic elements
within transcripts can be determined without ambiguity.
In this work we proposed a simple and efficient method for the
generation of isoform signatures that uniquely identify an
alternative splicing isoform. The method employs the well-known
SHA-1 cryptographic hashing algorithm, for which numerous
implementations exist in most common programming languages,
and can therefore be easily reimplemented. The resulting
identifiers are designed to be easily included in publications,
databases and existing informational resources. Isoform signatures
are a function of the exact arrangement of exons and introns in a
transcript, such that a change of even a single base in the length of
one of these elements guarantees an entirely different identifier.
Nevertheless, our method takes into account the fact that the
transcription start and end sites of a transcript cannot always be
determined exactly, and may span across few neighboring
positions. The use of normalized signatures allows matching of
isoforms that differ only in the exact positions of the TSS and TTS
within a predefined range. For example, the RefSeq database
contains three different isoforms for the human KLK5 gene. While
ASPICdb identifies all three isoforms exactly, ACEVIEW and
ASTD each contain only one isoform that matches one in RefSeq
exactly (a different one in each case), and two isoforms that match
the remaining two in RefSeq except for small changes in the TSS
Figure 4. The output of the Lookup command. The system displays the list of retrieved isoforms matching the supplied query terms, providing
information about their signatures and their structures. All the results displayed in this page can be downloaded to a local file.
doi:10.1371/journal.pone.0007631.g004
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display their contents or to download them to local files.
doi:10.1371/journal.pone.0007631.g005
Table 1. Pairwise comparisons between three alternative
splicing databases (ACEVIEW, ASTD, and ASPICdb) and RefSeq.
ACEVIEW ASTD ASPICdb RefSeq
ACEVIEW - 797/945 1691/2175 1531/1919
(6%/1%) (13%/2%) (8%/10%)
ASTD 3063/4520 - 1503/1692 519/548
(24%/6%) (12%/2%) (4%/3%)
ASPICdb 7874/14070 3983/5626 - 9262/12809
(62%/11%) (31%/7%) (62%/58%)
RefSeq 6514/8467 1866/2112 13848/19875 -
(41%/36%) (14%/10%) (93%/91%)
In each cell, the first figure is the number of genes in common between the two
databases (i.e., genes with at least one matching isoform), while the second
figure is the number of matching isoforms. The corresponding percentages are
reported below each pair of numbers. Only transcript variants from genes
present in both compared databases were considered. The position of the CDS
was taken into account when comparing isoforms in this analysis.
doi:10.1371/journal.pone.0007631.t001
Table 2. Pairwise comparisons between three alternative
splicing databases (ACEVIEW, ASTD, and ASPICdb) and RefSeq.
ACEVIEW ASTD ASPICdb RefSeq
ACEVIEW - 3043/4039 2725/3584 1963/2498
(24%/5%) (21%/3%) (12%/11%)
ASTD 7855/18159 - 2525/2979 822/862
(62%/25%) (20%/4%) (6%/4%)
ASPICdb 10020/23407 6281/10544 - 9377/12968
(79%/19%) (49%/14%) (63%/59%)
RefSeq 7960/10637 2945/3364 14086/20265 -
(50%/45%) (22%/17%) (94%/92%)
In each cell, the first figure is the number of genes in common between the two
databases (i.e., genes with at least one matching isoform), while the second
figure is the number of matching isoforms. The corresponding percentages are
reported below each pair of numbers. Only transcript variants from genes
present in both compared databases were considered. The position of the CDS
was not taken into account when comparing isoforms in this analysis.
doi:10.1371/journal.pone.0007631.t002
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different isoforms can be performed very easily using the method
we propose, by simply matching isoform signatures or the
corresponding signature strings.
We have developed a publicly-available, web-based tool to
facilitate the adoption and use of isoform signatures. The system
allows users to compute isoform signatures for one or more
alternative splicing isoforms at the same time, offering a variety of
different methods to describe the isoform structure, and provides
its results as a web page or as a downloadable delimited file. The
same tool can also be used to look up isoform signatures in a local
database containing all known and computationally predicted
isoforms for all human and mouse genes (other organisms will be
added over time). In this way the user can associate an isoform
signature with the corresponding alternative splicing isoform and
obtain detailed information about it, including the gene that it
belongs to, its exact structure, and its presence in different
databases. The method we described is in the public domain, and
we encourage publication authors and database developers to
adopt isoform signatures in their works, in order to reduce
ambiguities in the identification of alternatively spliced isoforms.
Methods
The following is the procedure we propose to compute the
signature of an alternative splicing isoform.
1. Consider a primary transcript sequence composed of alternat-
ing exons and introns. The sequence begins with the first
nucleotide of the first exon, and ends with the last nucleotide of
the last exon. We label each nucleotide with a progressive
number starting at 1. The label for the last nucleotide of the
sequence will be equal to the length of the sequence.
2. Collect the labels of the initial and final nucleotides of each
exon, in ascending numerical order (regardless of the strand
that the transcript is on). The first number in this sequence will
always be 1 by definition.
3. Create a signature string containing all the labels collected in step
2 except for the initial one (that is not necessary since it will
always be 1 by definition). The numbers should be written in
the string as decimal values separated by a forward slash (‘/’).
There should be no slash at the beginning or at the end of the
string.
4. Compute the SHA-1 cryptographic hash of this string [20].
The result is a sequence of 160 bits that can be written as a
string of 40 hexadecimal digits (padding it with 0 to the left if
necessary). The isoform signature consists of the first 10
hexadecimal digits (corresponding to the first 40 bits), followed
by a pipe character (‘|’), and by the number of exons in the
isoform.
If the position of the coding sequence is known, the last two
steps of the algorithm are modified in the following way:
a. Collect the positions of the start of the coding sequence (the
label of the ‘A’ nucleotide in the ATG) and of the end of the
coding sequence (the label of the third nucleotide in the stop
codon). Create a signature string containing the start and end
of the coding sequence followed by all the labels collected in
step 2 except for the initial one (that is not necessary since it
will always be 1 by definition). The numbers should be written
in the string as decimal values separated by a forward slash
(‘/’). There should be no slash at the beginning or at the end
of the string.
b. Compute the SHA-1 cryptographic hash of this string. The
result is a sequence of 160 bits that can be written as a string
of 40 hexadecimal digits (padding it with 0 to the left if
necessary). The isoform signature consists of the first 10
hexadecimal digits (corresponding to the first 40 bits), followed
by a colon character (‘:’), and by the number of exons in the
isoform.
To account for the fact that, as described above, the TSS and
TTS are not always exactly determined, and may span over a
limited genomic region, the algorithm is extended to generate an
additional set of ‘‘normalized’’ keys associated with each isoform.
Normalized keys are produced by forcing the lengths of the first
and last exons of the isoform to a fixed set of values. As will be
shown below, isoforms that differ only for the length of their initial
and/or final exons will share at least one of their normalized
signatures, and this fact can be used to establish a relationship
between them.
The following additional steps of the algorithm are used to
compute the four alternative signatures:
1. Choose an appropriate range of variability for the TSS (called
RS) and a similar range of variability for the TTS (RT). In this
work we used RS=R T=30 nt.
2. Let LS be the length of the first exon in the transcript.
Determine the multiple of RS immediately preceding LS and
the one immediately after it, and call them PS and QS. For
example, if LS is 213 nt and RS is 30, we obtain PS=210 and
QS=240.
3. Let LT be the length of the final exon in the transcript.
Determine the multiple of RT immediately preceding LS and
the one immediately after it, as in the previous step, calling
them PT and QT respectively.
4. Modify the start position of the first exon so that its length
becomes equal to PS, and the end position of the last exon so
that its length becomes equal to PT. Apply steps 3 and 4 above
to the resulting set of coordinates to generate an alternative
signature. Repeat using QS and PT,P S and QT,Q S and QT. The
result is a set of four different alternative signatures that are
associated with the primary signature obtained in the first part
of the algorithm.
This procedure ensures that if two gene isoforms differ only for
the position of the TSS (or of the TTS, or both) and the difference
between the positions is less than twice RS (or RT, respectively)
then their signatures will be different, but they will have at least
one of their four alternative signatures in common. See the next
section for an example. The value of 30 nt for RS and RT was
chosen empirically, observing the normal range of variation in the
start and end positions of transcripts, and looking for a tradeoff
between a more stringent definition of the isoform structures and
the requirement to recognize similar isoforms.
Although the isoform signature only contains one quarter of the
total number of bits produced by the cryptographic hash function,
it is still sufficient to represent over 10
12 different values, several
orders of magnitude more than the number of known and
predicted transcripts in a genome. While in theory there is a
chance that two different transcripts could generate the same
isoform signature (a collision), in practice the probability of this
event is extremely small, and is further reduced by the addition of
the number of exons at the end of the signature: a collision can
therefore only happen if two different isoforms, having the same
number of exons, produce hash values whose first 40 bits are
identical. We empirically evaluated the likelihood of this
3a.
5.
6.
7.
8.
4a.
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number of exons ranging from 2 to 100, and comparing the
signatures generated by them. We repeated this test 5 times, never
observing a single collision. The results of this test are available in
the Supplementary Materials section. Moreover, we generated
isoform signatures for all gene isoforms in the human and mouse
genome, including both known and computationally predicted
ones. Again, there was no collision between different isoforms in
this database.
Examples
Example 1. Consider the following hypothetical primary
transcript sequence, in which exons are indicated in uppercase and
introns in lowercase:
1234567890 1234567890 1234567890
1234567890 1234567890
1 TACAAAATCC GGGTCCGGGA GGTAGAGTTC
AATGCTCTCT ATCTgtgata
51 ggctcaagac gaccgggaat gaaacgagtt
gctagGATCC CCCTGTGAAC
101 CGCCTAGTAG TGAAGTCCAA ACGgtggcat
ctgtgcatag ttggcagTCA
151 AGTCCGCCGT CCTAAGCTGT CATGCATATG
CTTGGGCGGA CAATCGAGGC
The three exons are at positions 1 - 44, 86 - 133, and 148 - 200.
The signature string therefore is:
‘‘44/86/133/148/200’’
Applying the SHA1 algorithm to this string and converting the
result to hexadecimal characters, we obtain the following string:
‘‘2f3cac598c9788009f5096c8185643cad7fdee8c’’
And the isoform signature is therefore:
‘‘2f3cac598c|3’’
Example 2. The mRNA of human gene APOE (NM_000041)
is composed of 4 exons, encoded at the following positions on
chromosome 19 (according to NCBI build 36):
Start End Length
50,100,879 50,100,938 60
50,101,699 50,101,764 66
50,102,857 50,103,049 993
50,103,630 50,104,490 861
The coding sequence starts at position 50,101,721 and ends at
position 50,104,347. The signature string is therefore:
‘‘844/3469/60/821/886/1979/2171/2752/3612’’
where all positions are expressed relative to the start of the
transcript (50,100,879) and the first two numbers represent the
start and end of the coding sequence. The hexadecimal string
produced by the SHA-1 algorithm is:
‘‘197de3546e9d2e134120abb6038ccbdaef3a0292’’
And the isoform signature (in this case, an extended signature)
is:
‘‘197de3546e:4’’
To calculate the alternative signatures for this transcript, let us
first determine the length of the initial and final exons. In this case,
LS=60 and LT=861. Therefore, PS=30, QS=90, PT=840 and
QT=870. Note that, since in this example the length of the first
exon is already an exact multiple of 30, the previous and next
multiples are used. We therefore modify the coordinates of the
start of the first exon and of the end of the last exon (corresponding
to the start and the end of the transcript respectively) so that the
length of the first exon becomes 30 and the length of the last exon
becomes 840. The first set of new coordinates is then the following:
Start End Length
50,100,909 50,100,938 30
50,101,699 50,101,764 66
50,102,857 50,103,049 993
50,103,630 50,104,469 840
The modified coordinates are shown in bold face. Note that this
isoform, in general, will not be a biologically ‘‘real’’ one, but is only
generated to compute the first alternative isoform signature,
which,. in this case, will be the following:
‘‘a4b5a4e342:4’’
Any other isoform having the same exact structure as this one,
with a first exon whose length is between 1 and 60 and a last exon
whose length is between 810 and 870, will have a normalized
signature identical to this one (although its main signature will be
different), because the lengths of its first and last exons will become
30 and 840, respectively, by rounding them up or down
appropriately. The other three alternative signature strings are
calculated in a similar way, by setting the lengths of the first and
last exons to 90 and 840, 30 and 870, 90 and 870 respectively.
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